Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Instil Bio Inc

TIL ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: BUY

Last Close

$7.38

▲ +1.51%

Market Cap $50.05M · Vol 4.09K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$50.05M

Micro Cap

Div Yield

N/A

EPS Growth

+66.60%

YoY

RSI (14)

61.39

Momentum

Beta

1.90

vs Market

52W High

$33.78

78.15% below

52W Low

$5.67

30.16% above

Volume

4.09K

Avg 3.58K

P/B

0.66

Price-to-book

ROE

N/A

Return on equity

Free Float

93.44%

Public shares

Shariah Compliance8 STANDARDS

✗ Instil Bio Inc (TIL) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TIL pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-0.40%

-5.57%

-8.27%

-7.63%

YTD

-32.91%

-73.87%

-27.08%

-97.77%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-71,372,000.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-30.56% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	0.66
P/FCF	N/A
EPS Growth	+66.60%
Outstanding Shares	6.78M

Technical Indicators

50-Day SMA	$7.54
200-Day SMA	$9.05
RSI (14)	61.39
Beta	1.90
52-Week High	$33.78
52-Week Low	$5.67

Volume Today	4.09K
Avg Daily Volume (30D)	3.58K
Relative Volume	1.14x
Volatility (10D)	19.74
Volatility (30D)	19.95
Free Float	93.44%

Analyst Consensus

BUY

Current Price $7.38

Mean Target $7.00

52W Low$5.67 52W High$33.78

Current

Target

$5.67 $33.78

Current Analyst target

-5.15% downside risk · 3 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00ZGYN5X7

ISINUS45783C2008

CountryUnited States of America

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateNov 13, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. The Company’s subsidiary, Axion Bio, Inc., in-licensed certain bispecific antibodies, including AXN-2510/IMM2510 and AXN-27M/IMM27M, a monoclonal antibody targeting cytotoxic T-lymphocyte associated antigen 4, or CTLA-4. AXN-2510/IMM2510, the lead in-licensed product candidate, is a novel and differentiated PD-L1xVEGF bispecific antibody in development for the treatment of multiple solid tumor cancers. AXN-27M/IMM27M is an antibody-dependent cellular cytotoxicity-enhanced monoclonal antibody targeting CTLA-4, which has been designed to promote intratumoral regulatory T cell depletion to enhance the efficacy and reduce the toxicity associated with first-generation anti-CTLA-4 antibodies.